Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Retinoblastoma × Topotecan × Clear all

Phase

Phase 3 2 Phase 2 2 Phase 1 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Glioma 4 Brain Neoplasms 2 Retinoblastoma 1 Recurrence 1 Neoplasms 1 Lymphoma, Follicular 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06972602 2025-05-15

High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed

Eye & ENT Hospital of Fudan University

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Recurrence, Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡